"Serum SCCA-IgM as a predictor of hepatocellular carcinoma in patients with liver cirrhosis"
written by Daniela Buccione, Gianluca Fatti, Andrea Gallotta, Elisabetta Loggi, Roberto Di Donato, Lilia Testa, Carlo Saitta, Valentina Santi, Antonio Di Micoli, Virginia Erroi, Marta Frigerio, Valentina Fazio, Antonino Picciotto, Alessandra Biasiolo, Francoise Degos, Patrizia Pontisso, Giovanni Raimondo, Franco Trevisani,
published by Open Journal of Gastroenterology, Vol.2 No.2, 2012
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Clinical significances and diagnostic utilities of both miR-215 and squamous cell carcinoma antigen-IgM versus alpha-fetoprotein in Egyptian patients with …
2019
[2] SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy
2019
[3] Pro-oncogenic role of SerpinB3 in hepatocellular carcinoma
2018
[4] El antígeno de células neoplásicas escamosas (SCCA) solo o formando el complejo SCCA-igM es un biomarcador precoz de carcinoma hepatocelular.
2018
[5] Characterization of SCCA-IgM as a biomarker of liver disease in an Asian cohort of patients
Scandinavian Journal of Clinical and Laboratory Investigation, 2018
[6] Diagnostic accuracy of SCCA and SCCA‐IgM for hepatocellular carcinoma: A meta‐analysis
Liver International, 2018
[7] Biomarkers development for early detection of cancer: Reducing the burden of cancer in the ageing society
The EuroBiotech Journal, 2018
[8] Circulating SCCA–IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients
Journal of Research in Childhood Education, 2017
[9] Squamous Cell Carcinoma Antigen-Immunoglobulin M (SCCA-IgM) as Biomarker in Liver Disease: Biological Aspects and Clinical Applications
Biomarkers in Liver Disease, 2016
[10] WJCID
World, 2015
[11] Clinical applications of squamous cell carcinoma antigen-immunoglobulins M to monitor chronic hepatitis C
World journal of hepatology, 2015
[12] Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study
Digestive and Liver Disease, 2015
[13] New biomarkers for clinical management of hepatitis C virus infected patients
World J Clin Infect Dis, 2015
[14] Clinical applications of squamous cell carcinoma antigen-IgM to monitor chronic hepatitis C
World Journal of Hepatology, 2015
[15] Squamous cell carcinoma antigen in hepatocellular carcinoma: Ready for the prime time?
Clinica Chimica Acta, 2015
[16] HCV genotype 3 and squamous cell carcinoma antigen (SCCA)‐IgM are independently associated with histological features of NASH in HCV‐infected patients
Journal of Viral Hepatitis, 2015
[17] Adrenal insufficiency in patients with decompensated cirrhosis
World Journal of Hepatology, 2015
[18] Analytical validation of a Biochip prototype for integrated analysis of AFP-IgM and SCCA-IgM serum biomarkers in patients with liver cirrhosis and hepatocellular …
Analytical Methods, 2015
[19] Serum SCCA-IgM can predict the development of hepatocellular carcinoma in patients with HCV-related cirrhosis.
2015
[20] Analytical validation of a Biochip prototype for integrated analysis of AFP-IgM and SCCA-IgM serum biomarkers in patients with liver cirrhosis and hepatocellular …
Analytical Methods, 2015
[21] Analytical validation of a Biochip prototype for integrated analysis of AFP-IgM and SCCA-IgM serum biomarkers in patients with liver cirrhosis and hepatocellular carcinoma
Analytical Methods, 2015
[22] Role of SERPINB3 in hepatocellular carcinoma.
Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2014
[23] Role of SERPINB3 in hepatocellular carcinoma
2014
[24] Evaluation of squamous cell carcinoma antigen-immunoglobulin M complex (SCCA-IGM) and alpha-l-fucosidase (AFU) as novel diagnostic biomarkers for hepatocellular carcinoma
Tumor Biology, 2014
[25] Serum Squamous Cell Carcinoma Antigen Level in Cirrhotic Chronic Hepatitis C Patients With and Without Hepatocellular Carcinoma
Gastroenterology and Hepatology, 2014
[26] Evaluation of squamous cell carcinoma antigen-immunoglobulin M complex (SCCA-IGM) and alpha-l-fucosidase (AFU) as novel diagnostic biomarkers for …
Tumor Biology, 2014
[27] Specificity of squamous cell carcinoma antigen (SCCA)‐IgM detection in patients with HCV infection and rheumatoid factor seropositivity
Journal of medical virology, 2013